A detailed history of Napatree Capital LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Napatree Capital LLC holds 2,712 shares of ZTS stock, worth $447,046. This represents 0.37% of its overall portfolio holdings.

Number of Shares
2,712
Previous 2,500 8.48%
Holding current value
$447,046
Previous $433 Million 22.26%
% of portfolio
0.37%
Previous 0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$172.58 - $196.48 $36,586 - $41,653
212 Added 8.48%
2,712 $530 Million
Q2 2024

Aug 13, 2024

BUY
$145.54 - $178.83 $363,850 - $447,075
2,500 New
2,500 $433 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Napatree Capital LLC Portfolio

Follow Napatree Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Napatree Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Napatree Capital LLC with notifications on news.